Stockhub

INSYS Therapeutics, Inc.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

23 September 2022

  • curprev 11:4111:41, 23 September 2022 95.149.241.133 talk 1,223 bytes +1,223 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == On February 18, 2020, INSYS Therapeutics, Inc. went out of business as per its Chapter 11 liquidation filing under bankruptcy. Insys Therapeutics, Inc., a specialty pharmaceutical company, focuses on cannabinoids and drug delivery systems that address unmet patient needs. The company markets SUBSYS, a sublingual fentanyl spray for breakthrough cancer pain in opioid-tolerant adult patients; and SYNDROS, an orally administere..."
Retrieved from "https://stockhub.co/research/INSYS_Therapeutics,_Inc."